Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

E-ISSN： 1939-1676|29|4|1098-1104

ISSN： 0891-6640

Source： Journal Of Veterinary Internal Medicine, Vol.29, Iss.4, 2015-07, pp. : 1098-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Journal Of Veterinary Internal Medicine, Vol. 32, Iss. 1, 2018-01 ,pp. : 394-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs

Journal Of Veterinary Internal Medicine, Vol. 32, Iss. 1, 2018-01 ,pp. : 377-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of lithium carbonate to prevent lomustine-induced myelosuppression in dogs: A pilot study

By Abrams-Ogg Anthony C.G.

Canadian Journal of Veterinary Research, Vol. 75, Iss. 1, 2011-01 ,pp. : 73-76

Canadian Veterinary Medical Association

Access to resources Recommend Favorite

In vitro chemosensitivity of canine mast cell tumors grades II and III to all- trans -retinoic acid (ATRA).

By Pinello K.

Veterinary Research Communications, Vol. 33, Iss. 6, 2009-08 ,pp. : 581-588

Springer Publishing Company

Access to resources Recommend Favorite

Infrared Thermography in Dogs with Mammary Tumors and Healthy Dogs

Journal Of Veterinary Internal Medicine, Vol. 29, Iss. 6, 2015-11 ,pp. : 1578-1583

John Wiley & Sons Inc

Access to resources Recommend Favorite